Filter posts

CMS’s Own Data Do NOT Support Claims on Part B Drug Spending

In a story entitled, “CMS Blames Medicare Part B Hikes on Drug Costs,” writers for …

Expanding Benefits to Members, BIO Now Offering Education and Training Courses

BIO is continually looking for ways to help its members grow and prosper. This week …

The Pelosi Plan and "Me Too" Drugs

Supporters of Speaker Pelosi’s drug pricing plan (H.R. 3) claim the bill will discourage the …

BIO's Leadership Transition | "The fight continues..."

On Tuesday, October 8, BIO formally announced that its President and CEO Jim Greenwood would …

Pitch Perfect – Storytelling is Key for BIO One-on-One Partnering

Keith Ignotz knows the power of a good story. The President & CEO of OcuMedic—an early …

Influential investor, Wende Hutton, to Speak at #BIF19

In a few short months BIO will be hosting the BIO Investor Forum (#BIF19) for …

#BIOWC19 Day 3 Wrap-Up: Bringing People, Ideas, and Technology Together

Day three of the 2019 BIO World Congress began by awarding three individuals who have had …

Congressman Stiver Continues Call for Sensible Patent Reform

Congressman Stiver Continues Call for Sensible Patent Reform While there is consensus across Capitol Hill …

When Intervention Stifles Innovation

Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore …

It Starts with One…Winning Presentation at the Start-up Stadium

Dr. Akshaya Shanmugam has always believed that healthcare should be accessible and affordable to everyone …